SEC 13F Intelligence

Managers / Q2 2021 · view latest →

DSAM Partners (London) Ltd

CIK 0001565061 · 14-15 CONDUIT STREET, LONDON, X0, W1S 2XJ · 442070168600

Reported Value
$595M
Q2 2021
Positions
45
Filings on Record
16
2019–present window
Filed
Aug 16, 2021
original filing

Summary

Dsam Partners (London) Ltd reported $595M in U.S.-listed holdings across 45 positions for Q2 2021.

Its largest position, GFL, represents 6.7% of the portfolio.

Compared with Q1 2021, the fund opened 13 new positions and exited 15.

Portfolio Metrics

Turnover
+33.9%
vs prior filed quarter
Top-10 Concentration
+57.8%
share of reported value
Largest Position
+6.7%
Gfl Environmental
New / Exited
13 / 15
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $481MQ4 ’18Q1 ’19: $692MQ2 ’19: $805MQ2 ’19Q3 ’19: $536MQ4 ’19: $436MQ4 ’19Q1 ’20: $423MQ2 ’20: $383MQ2 ’20Q3 ’20: $578MQ4 ’20: $854MQ4 ’20Q1 ’21: $539MQ2 ’21: $595MQ2 ’21Q3 ’21: $176Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 90.7%Other: 9.3%
  • Common Stock · 90.7% · $540M
  • Other · 9.3% · $56M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2021 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
STEMSTEM INCNEW+881.0K881.0K+$32M$32M
VYXNCR CORP NEWNEW+654.6K654.6K+$30M$30M
STLASTELLANTIS N.VNEW+1.28M1.28M+$25M$25M
PTONPELOTON INTERACTIVE INCNEW+180.0K180.0K+$22M$22M
INTUINTUITNEW+43.5K43.5K+$21M$21M
XPOXPO LOGISTICS INCNEW+150.9K150.9K+$21M$21M
AEVA TECHNOLOGIES INCNEW+1.50M1.50M+$16M$16M
AMZNAMAZON COM INCNEW+4.3K4.3K+$15M$15M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2021

45 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1GFLGFL ENVIRONMENTAL INChistory →SUB VTG SHS6.71%$40M1.25M
2MSFTMICROSOFT CORPhistory →COM6.42%$38M141.1K
3EXPEEXPEDIA GROUP INChistory →COM NEW6.32%$38M230.0K
4ARANTERO RESOURCES CORPhistory →COM6.32%$38M2.50M
5GOOGALPHABET INChistory →CAP STK CL C5.94%$35M14.1K
6VNTVONTIER CORPORATIONhistory →COM5.79%$34M1.06M
7OXYOCCIDENTAL PETE CORPhistory →COM5.74%$34M1.09M
8STEMSTEM INChistory →COM5.33%$32M881.0K
9VYXNCR CORP NEWhistory →COM5.01%$30M654.6K
10STLASTELLANTIS N.Vhistory →SHS4.23%$25M1.28M
11MUMICRON TECHNOLOGY INChistory →COM3.80%$23M266.0K
12PTONPELOTON INTERACTIVE INChistory →CL A COM3.75%$22M180.0K
13INTUINTUIThistory →COM3.58%$21M43.5K
14XPOXPO LOGISTICS INChistory →COM3.55%$21M150.9K
15CARRCARRIER GLOBAL CORPORATIONhistory →COM2.74%$16M335.9K
16AEVA TECHNOLOGIES INCCOM2.66%$16M1.50M
17AMZNAMAZON COM INChistory →COM2.48%$15M4.3K
18CSTMCONSTELLIUM SEhistory →CL A SHS2.15%$13M675.0K
19AONAON PLChistory →SHS CL A1.68%$10M42.0K
20ONECOM CL A1.67%$10M993.6K
21CHURCHILL CAPITAL CORP IVCL A1.60%$10M330.3K
22DECARBONIZATION PLUS ACQU COCOM CL A1.23%$7M709.8K
23TORTOISE ACQUISITION CORP IICOM CL A1.07%$6M635.9K
24RCKTROCKET PHARMACEUTICALS INChistory →COM1.04%$6M140.3K
25BBIOBRIDGEBIO PHARMA INCCOM0.82%$5M80.4K
26KRYSKRYSTAL BIOTECH INCCOM0.80%$5M70.3K
27DMY TECHNOLOGY GROUP INC IIICOM CLASS A0.77%$5M426.7K
28CLDXCELLDEX THERAPEUTICS INC NEWCOM NEW0.76%$5M135.9K
29MELIMERCADOLIBRE INCCOM0.65%$4M2.5K
30NBISYANDEX N VSHS CLASS A0.65%$4M55.0K
31ALLOALLOGENE THERAPEUTICS INCCOM0.63%$4M144.0K
32EPAMEPAM SYS INCCOM0.56%$3M6.5K
33MLMMARTIN MARIETTA MATLS INCCOM0.48%$3M8.1K
34VMCVULCAN MATLS COCOM0.37%$2M12.6K
35IOVAIOVANCE BIOTHERAPEUTICS INCCOM0.36%$2M81.6K
36IMMATICS N.VSHS0.30%$2M153.0K
37CVECENOVUS ENERGY INCCOM0.28%$2M171.0K
38OPCHOPTION CARE HEALTH INCCOM NEW0.27%$2M74.6K
39OVVOVINTIV INCCOM0.27%$2M51.8K
40SUMMIT MATLS INCCL A0.26%$2M43.7K
41NEXIMMUNE INCCOM0.25%$1M89.5K
42APLTAPPLIED THERAPEUTICS INCCOM0.23%$1M67.1K
43EXPEAGLE MATLS INCCOM0.23%$1M9.6K
44AFIBACUTUS MED INCCOM0.20%$1M71.8K
45ARYA SCIENCES ACQU CORP IVCL A0.04%$214,00020.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2021$176M18Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$595M45Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$539M47May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$854M58Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020REVEALED$578M37Nov 18, 2020RESTATEMENTchanges · EDGAR ↗
Q2 2020$383M30Nov 18, 2020RESTATEMENTchanges · EDGAR ↗
Q1 2020$423M31May 15, 2020RESTATEMENTchanges · EDGAR ↗
Q4 2019$436M48Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$536M63Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$805M86Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$692M86May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$481M37Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.